Page 82 - GPD-2-1

Gene & Protein in Disease m1A-mediated ESCCAL-1 promotes ESCA stemness

https://doi.org/10.3390/genes13050910 perspectives. Comput Struct Biotechnol J, 20: 6578––6585.
12. Chen Z, Qi M, Shen B, et al., 2019, Transfer RNA https://doi.org/10.1016/j.csbj.2022.11.045
demethylase ALKBH3 promotes cancer progression via 22. Paul R, Dorsey JF, Fan Y, 2022, Cell plasticity, senescence, and
induction of tRNA-derived small RNAs. Nucleic Acids Res, quiescence in cancer stem cells: Biological and therapeutic
47(5): 2533–2545.
implications. Pharmacol Ther, 231: 107985.
https://doi.org/10.1093/nar/gky1250
https://doi.org/10.1016/j.pharmthera.2021.107985
13. Wang Y, Wang J, Li X, et al., 2021, N1-methyladenosine 23. Du L, Cheng Q, Zheng H, et al., 2022, Targeting stemness of
methylation in tRNA drives liver tumourigenesis by regulating cancer stem cells to fight colorectal cancers. Semin Cancer
cholesterol metabolism. Nat Commun, 12(1): 6314.
Biol, 82: 150–161.
https://doi.org/10.1038/s41467-021-26718-6
https://doi.org/10.1016/j.semcancer.2021.02.012
14. Wu Y, Chen Z, Xie G, et al., 2022, RNA m A methylation 24. Liu C, Zhang Y, Gao J, et al., 2022, A highly potent small-
1
regulates glycolysis of cancer cells through modulating molecule antagonist of exportin-1 selectively eliminates
ATP5D. Proc Natl Acad Sci U S A, 119(28): e2119038119.
CD44+CD24-enriched breast cancer stem-like cells. Drug
https://doi.org/10.1073/pnas.2119038119 Resist Updat, 66: 100903.
15. Lu Q, Wang H, Lei X, et al., 2022, LncRNA ALKBH3-AS1 https://doi.org/10.1016/j.drup.2022.100903
enhances ALKBH3 mRNA stability to promote 25. Ervin EH, French R, Chang CH, et al., 2022, Inside the
hepatocellular carcinoma cell proliferation and invasion. stemness engine: Mechanistic links between deregulated
J Cell Mol Med, 26(20): 5292–5302.
transcription factors and stemness in cancer. Semin Cancer
https://doi.org/10.1111/jcmm.17558 Biol, 87: 48–83.
16. Nallasamy P, Nimmakayala RK, Parte S, et al., 2022, Tumor https://doi.org/10.1016/j.semcancer.2022.11.001
microenvironment enriches the stemness features: The 26. Taheri M, Khoshbakht T, Jamali E, et al., 2021, Interaction
architectural event of therapy resistance and metastasis. Mol between non-coding RNAs and androgen receptor with an
Cancer, 21(1): 225.
especial focus on prostate cancer. Cells, 10(11): 3198.
https://doi.org/10.1186/s12943-022-01682-x
https://doi.org/10.3390/cells10113198
17. Chaudhary A, Raza SS, Haque R, 2023, Transcriptional 27. Tortora F, Calin GA, Cimmino A, 2021, Effects of long
factors targeting in cancer stem cells for tumor modulation. non-coding RNAs on androgen signaling pathways
Semin Cancer Biol, 88: 123–137.
in genitourinary malignancies. Mol Cell Endocrinol,
https://doi.org/10.1016/j.semcancer.2022.12.010 526: 111197.
18. Wilkinson E, Cui YH, He YY, 2022, Roles of RNA https://doi.org/10.1016/j.mce.2021.111197
modifications in diverse cellular functions. Front Cell Dev 28. Huang F, Chen H, Zhu X, et al., 2021, The oncogenomic
Biol, 10: 828683.
function of androgen receptor in esophageal squamous cell
https://doi.org/10.3389/fcell.2022.828683 carcinoma is directed by GATA3. Cell Res, 31(3): 362–365.
19. Wang Z, He J, Bach DH, et al., 2022, Induction of m6A https://doi.org/10.1038/s41422-020-00428-y
methylation in adipocyte exosomal LncRNAs mediates 29. Zhao Y, Zhao Q, Kaboli PJ, et al., 2019, m A regulated
1
myeloma drug resistance. J Exp Clin Cancer Res, 41(1): 4.
genes modulate PI3K/AKT/mTOR and ErbB pathways in
https://doi.org/10.1186/s13046-021-02209-w gastrointestinal cancer. Transl Oncol, 12(10): 1323–1333.
20. Cui L, Ma R, Cai J, et al., 2022, RNA modifications: https://doi.org/10.1016/j.tranon.2019.06.007
Importance in immune cell biology and related diseases. 30. Woo HH, Chambers SK, 2019, Human ALKBH3-induced
Signal Transduct Target Ther, 7(1): 334.
m A demethylation increases the CSF-1 mRNA stability in
1
https://doi.org/10.1038/s41392-022-01175-9 breast and ovarian cancer cells. Biochim Biophys Acta Gene
Regul Mech, 1862(1): 35–46.
21. Li J, Zhang H, Wang H, 2022, N1-methyladenosine
modification in cancer biology: Current status and future https://doi.org/10.1016/j.bbagrm.2018.10.008

Volume 2 Issue 1 (2023) 10 https://doi.org/10.36922/gpd.305